Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density

Cancer Research

Volumn 60, Issue 14, 2000, Pages 3744-3748

  Byrne, Celia ^a   Colditz, Graham A ^a,b   Willett, Walter C ^a,b   Speizer, Frank E ^a,b   Pollak, Michael ^c   Hankinson, Susan E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; BREAST; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MAMMOGRAPHY; MIDDLE AGED; PLASMA; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 0034660884     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Endocrine effect of IGF-I on normal and transformed breast epithelial cells: Potential relevance to strategies for breast cancer treatment and prevention
2. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
3. Insulin-like growth factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer
4. Plasma insulin-like growth factor-1 (IGF-I) concentration in human breast cancer
5. Insulin-like growth factor-1 in relation to premenopausal ductal carcinoma in situ of the breast
6. Mammographic features and breast cancer risk: Effects with time, age and menopause status
7. Mammographic parenchymal patterns: A marker of breast cancer risk
8. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women
9. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels
10. Effect of replacement estrogen on insulin-like growth factor-1 in postmenopausal women: The Rancho Bernardo Study
11. Mammographic changes associated with postmenopausal hormone replacement therapy: A longitudinal study
12. The mammographic parenchymal patterns of women on hormonal replacement therapy
13. Effects of estrogen and estrogen-progestin on the mammographic parenchymal density
14. Epidemiology of insulin-like growth factor-1 in elderly men and women
15. Symmetry of projection in the quantitative analysis of mammographic images
16. The quantitative analysis of mammographic densities
17. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study
18. Mammographic density and breast cancer risk: The evolution of assessment techniques and implications for understanding breast cancer
19. Mammographic parenchymal patterns and breast cancer risk
20. Nutritional regulation of the insulin-like growth factors
21. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-I, IGFBP-2, age, sex, body mass index, and pubertal maturation
22. Mammographic densities and breast cancer risk
23. Expression and regulation of insulin-like growth factors and their binding proteins in the normal breast
24. IGF-I physiology, and breast cancer
25. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat
26. Insulin-like growth factor-binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation
27. Effect of tamoxifen on serum insulin-like growth factor 1 levels in stage I breast cancer patients
28. Mammographic patterns as a predictive biomarker of breast cancer risk: Effect of tamoxifen
29. Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with premenstrual syndrome
30. Relationship between insulin-like growth factor-1 and estradiol in reproductive aging
31. Serum levels cf insulin-like growth factor 1 and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles
32. Serum and follicular fluid levels of insulin-like growth factor 1 (IGF-I). IGF-II and IGF-binding protein-1 and -3 during the normal menstrual cycle
33. Interactions between the oestrogen and insulin-like growth factor signaling pathways in the control of breast epithelial cell proliferation